Advances in Neural Stem Cell Therapy for Spinal Cord Injury: Safety, Efficacy, and Future Perspectives

Overview

Journal Neurospine

Date 2022 Nov 9

PMID 36351442

Authors

Sungjoon Lee

Hyun Nam

Kyeung-Min Joo

Sun-Ho Lee

Affiliations

Soon will be listed here.

Abstract

Spinal cord injury (SCI) is a devastating central nervous system injury that leads to severe disabilities in motor and sensory functions, causing significant deterioration in patients' quality of life. Owing to the complexity of SCI pathophysiology, there has been no effective treatment for reversing neural tissue damage and recovering neurological functions. Several novel therapies targeting different stages of pathophysiological mechanisms of SCI have been developed. Among these, treatments using stem cells have great potential for the regeneration of damaged neural tissues. In this review, we have summarized recent preclinical and clinical studies focusing on neural stem cells (NSCs). NSCs are multipotent cells with specific differentiation capabilities for neural lineage. Several preclinical studies have demonstrated the regenerative effects of transplanted NSCs in SCI animal models through both paracrine effects and direct neuronal differentiation, restoring synaptic connectivity and neural networks. Based on the positive results of several preclinical studies, phase I and II clinical trials using NSCs have been performed. Despite several hurdles and issues that need to be addressed in the clinical use of NSCs in patients with SCI, gradual progress in the technical development and therapeutic efficacy of NSCs treatments has enhanced the prospects for cell-based treatments in SCI.

Citing Articles

Induced Neural Stem Cell Transplantation in Spinal Cord Injury: Present Status and Next Steps.

Jung J, Jeong J, Ko M, Lee B, Kwon W, Jeon S Korean J Neurotrauma. 2025; 20(4):234-245.

PMID: 39803345 PMC: 11711022. DOI: 10.13004/kjnt.2024.20.e45.

Safety and Efficacy of Autologous Bone Marrow Derived Mononuclear Cell Transplant in the Management of Various Neurological Disorders.

Kala S, Aggarwal A, Singh Rajput B, Kala C, Barman S Cureus. 2025; 16(12):e75617.

PMID: 39803099 PMC: 11725325. DOI: 10.7759/cureus.75617.

Synergistic effects of human umbilical cord mesenchymal stem cells/neural stem cells and epidural electrical stimulation on spinal cord injury rehabilitation.

Mu Z, Qin J, Zhou X, Wang K Sci Rep. 2024; 14(1):26090.

PMID: 39478010 PMC: 11526023. DOI: 10.1038/s41598-024-75754-x.

Sbno1 mediates cell-cell communication between neural stem cells and microglia through small extracellular vesicles.

Zhang Y, Zhu Z, Li Z, Feng J, Long J, Deng Y Cell Biosci. 2024; 14(1):125.

PMID: 39343943 PMC: 11441009. DOI: 10.1186/s13578-024-01296-4.

Repeated intrathecal injections of peripheral nerve-derived stem cell spheroids improve outcomes in a rat model of traumatic brain injury.

Shin H, Lee W, Park K, Yu Y, Kim G, Roh E Stem Cell Res Ther. 2024; 15(1):314.

PMID: 39300591 PMC: 11414269. DOI: 10.1186/s13287-024-03874-2.

References

Obernier K, Alvarez-Buylla A . Neural stem cells: origin, heterogeneity and regulation in the adult mammalian brain. Development. 2019; 146(4). PMC: 6398449. DOI: 10.1242/dev.156059. View

Cheng I, Githens M, Smith R, Johnston T, Park D, Stauff M . Local versus distal transplantation of human neural stem cells following chronic spinal cord injury. Spine J. 2015; 16(6):764-9. DOI: 10.1016/j.spinee.2015.12.007. View

Nemati S, Jabbari R, Hajinasrollah M, Zare Mehrjerdi N, Azizi H, Hemmesi K . Transplantation of adult monkey neural stem cells into a contusion spinal cord injury model in rhesus macaque monkeys. Cell J. 2014; 16(2):117-130. PMC: 4072074. View

Li Y, Walker C, Zhang Y, Shields C, Xu X . Surgical decompression in acute spinal cord injury: A review of clinical evidence, animal model studies, and potential future directions of investigation. Front Biol (Beijing). 2014; 9(2):127-136. PMC: 4041293. DOI: 10.1007/s11515-014-1297-z. View

Tang Y, Yu P, Cheng L . Current progress in the derivation and therapeutic application of neural stem cells. Cell Death Dis. 2017; 8(10):e3108. PMC: 5682670. DOI: 10.1038/cddis.2017.504. View

Karova K, Wainwright J, Machova-Urdzikova L, Pisal R, Schmidt M, Jendelova P . Transplantation of neural precursors generated from spinal progenitor cells reduces inflammation in spinal cord injury via NF-κB pathway inhibition. J Neuroinflammation. 2019; 16(1):12. PMC: 6335809. DOI: 10.1186/s12974-019-1394-7. View

Ullah I, Subbarao R, Rho G . Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015; 35(2). PMC: 4413017. DOI: 10.1042/BSR20150025. View

Yamazaki K, Kawabori M, Seki T, Houkin K . Clinical Trials of Stem Cell Treatment for Spinal Cord Injury. Int J Mol Sci. 2020; 21(11). PMC: 7313002. DOI: 10.3390/ijms21113994. View

Gage F, Temple S . Neural stem cells: generating and regenerating the brain. Neuron. 2013; 80(3):588-601. DOI: 10.1016/j.neuron.2013.10.037. View

10.

Lu P, Wang Y, Graham L, McHale K, Gao M, Wu D . Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell. 2012; 150(6):1264-73. PMC: 3445432. DOI: 10.1016/j.cell.2012.08.020. View

11.

Kadoya K, Lu P, Nguyen K, Lee-Kubli C, Kumamaru H, Yao L . Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration. Nat Med. 2016; 22(5):479-87. PMC: 4860037. DOI: 10.1038/nm.4066. View

12.

Gincberg G, Arien-Zakay H, Lazarovici P, Lelkes P . Neural stem cells: therapeutic potential for neurodegenerative diseases. Br Med Bull. 2012; 104:7-19. DOI: 10.1093/bmb/lds024. View

13.

Gurusamy N, Alsayari A, Rajasingh S, Rajasingh J . Adult Stem Cells for Regenerative Therapy. Prog Mol Biol Transl Sci. 2018; 160:1-22. DOI: 10.1016/bs.pmbts.2018.07.009. View

14.

Rong Y, Liu W, Wang J, Fan J, Luo Y, Li L . Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy. Cell Death Dis. 2019; 10(5):340. PMC: 6472377. DOI: 10.1038/s41419-019-1571-8. View

15.

Levi A, Okonkwo D, Park P, Jenkins 3rd A, Kurpad S, Parr A . Emerging Safety of Intramedullary Transplantation of Human Neural Stem Cells in Chronic Cervical and Thoracic Spinal Cord Injury. Neurosurgery. 2017; 82(4):562-575. DOI: 10.1093/neuros/nyx250. View

16.

Huang L, Wang Y, Zhu M, Wan X, Zhang H, Lei T . Anisotropic Alginate Hydrogels Promote Axonal Growth across Chronic Spinal Cord Transections after Scar Removal. ACS Biomater Sci Eng. 2021; 6(4):2274-2286. DOI: 10.1021/acsbiomaterials.9b01802. View

17.

Liu S, Yang H, Chen D, Xie Y, Tai C, Wang L . Three-dimensional bioprinting sodium alginate/gelatin scaffold combined with neural stem cells and oligodendrocytes markedly promoting nerve regeneration after spinal cord injury. Regen Biomater. 2022; 9:rbac038. PMC: 9255276. DOI: 10.1093/rb/rbac038. View

18.

Westerlund U, Svensson M, Moe M, Varghese M, Gustavsson B, Wallstedt L . Endoscopically harvested stem cells: a putative method in future autotransplantation. Neurosurgery. 2005; 57(4):779-84. View

19.

Badhiwala J, Ahuja C, Fehlings M . Time is spine: a review of translational advances in spinal cord injury. J Neurosurg Spine. 2019; 30(1):1-18. DOI: 10.3171/2018.9.SPINE18682. View

20.

Farid M, Abouelela Y, Rizk H . Stem cell treatment trials of spinal cord injuries in animals. Auton Neurosci. 2022; 238:102932. DOI: 10.1016/j.autneu.2021.102932. View